RMGLOBAL Healthcare Investment Banking and Advisory
RM Global is a global life science investment banking and strategic advisory firm focused in life sciences, including biopharma, biotech, medical devices, consumer/digital health, and diagnostics. Our expertise is in M&A, raising venture, growth, bridge and private equity financing, valuation advice, transaction structures, deal tactics/negotiations, corporate venture capital management, strategic consulting services. RMG provides both in-licensing and out-licensing services to facilitate technology transfer and portfolio enhancement. RM Global has a network of a diverse client base including the Americas, Europe, Israel, and Asia: Korea, Japan, and China.
RMGLOBAL Healthcare Fund Management
RMGP Biopharma Investment Fund is a Venture Capital (VC) Fund that invests in innovative, early stage biopharma assets, through its partnership with FutuRx. FutuRx is an Israel-based, globally focused drug development platform, founded by Orbimed, Johnson&Johnson and Takeda. RMGP's partnership with the incubator provides access to projects carefully selected by industry professionals, with potential to be first-in-class or best-in-class treatments for therapeutic areas with high unmet need (e.g.: oncology, rare diseases, autoimmune diseases, cardiovascular and metabolic diseases, neurodegenerative and other CNS disorders)